Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. H. Res. 685. 119th Cong., 1st sess., Introduced in House September 9, 2025. https://www.govinfo.gov/app/details/BILLS-119hres685ih.
Congress, House of Representatives (2025, September 9). Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. (H. Res. 685 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hres685ih.
United States, Congress, House of Representatives. Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hres685ih. 119th Congress, H. Res. 685, Introduced in House 9 Sep. 2025.
H.Res.685 - 119th Congress (2025-2026): Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes., H.Res.685, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hres685ih.